World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
71
Citations
23904
World Ranking
2281
National Ranking
1106

Overview

Paul A. Goepfert is affiliated with the University of Alabama at Birmingham in the United States. Their research spans across medicine, immunology, and microbiology, focusing particularly on infectious diseases, immunology, virology, epidemiology, and molecular biology.

The scientist has contributed extensively to various topics, including:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • HIV Research and Treatment
  • Immune Cell Function and Interaction
  • Long-Term Effects of COVID-19
  • Vaccines and Immunoinformatics Approaches
  • T-cell and B-cell Immunology

The publication record of Paul A. Goepfert includes papers in several key venues such as bioRxiv (Cold Spring Harbor Laboratory), UNC Libraries, Nature Communications, Vaccine, and the Journal of Clinical Investigation. Their frequent co-authors include Lawrence Corey, Lindsey R. Baden, Peter B. Gilbert, Glenda Gray, and Beatriz Grinsztejn.

Among recent notable papers authored or co-authored by Paul A. Goepfert are:

  • Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19, 2021, New England Journal of Medicine
  • Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S, 2022, New England Journal of Medicine
  • TOX is expressed by exhausted and polyfunctional human effector memory CD8 + T cells, 2020, Science Immunology
  • Sustained cellular immune dysregulation in individuals recovering from SARS-CoV-2 infection, 2020, Journal of Clinical Investigation
  • Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial, 2022, The Lancet Respiratory Medicine

Best Publications

  • Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.

    Jerald Sadoff;Glenda Gray;An Vandebosch;Vicky Cárdenas

  • Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection

    Brandon F. Keele;Elena E. Giorgi;Elena E. Giorgi;Jesus F. Salazar-Gonzalez;Julie M. Decker

  • HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T-cells

    Michael R. Betts;Martha C. Nason;Sadie M. West;Stephen C. De Rosa

  • The major genetic determinants of HIV-1 control affect HLA class I peptide presentation

    Pereyra F;Jia X;McLaren Pj

  • Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies

    Ming Li;Feng Gao;John R. Mascola;Leonidas Stamatatos

  • Quantum dot semiconductor nanocrystals for immunophenotyping by polychromatic flow cytometry

    Pratip K Chattopadhyay;David A Price;Theresa F Harper;Michael R Betts;Michael R Betts

  • Magnitude of Functional CD8+ T-Cell Responses to the Gag Protein of Human Immunodeficiency Virus Type 1 Correlates Inversely with Viral Load in Plasma

    Bradley H. Edwards;Anju Bansal;Steffanie Sabbaj;Janna Bakari

  • Perforin Expression Directly Ex Vivo by HIV-Specific CD8 + T-Cells Is a Correlate of HIV Elite Control

    Adam R. Hersperger;Florencia Pereyra;Martha Nason;Korey R. Demers

  • Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S

    Unknown

  • Escape and Compensation from Early HLA-B57-Mediated Cytotoxic T-Lymphocyte Pressure on Human Immunodeficiency Virus Type 1 Gag Alter Capsid Interactions with Cyclophilin A

    Mark A. Brockman;Arne Schneidewind;Matthew Lahaie;Aaron Schmidt;Aaron Schmidt

  • Compensatory Mutation Partially Restores Fitness and Delays Reversion of Escape Mutation within the Immunodominant HLA-B*5703-Restricted Gag Epitope in Chronic Human Immunodeficiency Virus Type 1 Infection

    Hayley Crawford;Julia G. Prado;Alasdair Leslie;Stéphane Hué

  • Selection bias at the heterosexual HIV-1 transmission bottleneck

    Jonathan M. Carlson;Malinda Schaefer;Daniela C. Monaco;Rebecca Batorsky

  • Immune suppression by neutrophils in HIV-1 infection: role of PD-L1/PD-1 pathway.

    Nathan L. Bowers;E. Scott Helton;Richard P. H. Huijbregts;Paul A. Goepfert

  • Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients

    Paul A. Goepfert;Wendy Lumm;Paul Farmer;Philippa Matthews

  • A Significant Number of Human Immunodeficiency Virus Epitope-Specific Cytotoxic T Lymphocytes Detected by Tetramer Binding Do Not Produce Gamma Interferon

    Paul A. Goepfert;Anju Bansal;Bradley H. Edwards;G. Douglas Ritter

  • Initial antibodies binding to HIV-1 gp41 in acutely infected subjects are polyreactive and highly mutated

    Hua-Xin Liao;Xi Chen;Supriya Munshaw;Ruijun Zhang

  • Polyclonal B cell differentiation and loss of gastrointestinal tract germinal centers in the earliest stages of HIV-1 infection.

    Marc C. Levesque;M. Anthony Moody;Kwan Ki Hwang;Dawn J. Marshall

  • Modeling sequence evolution in acute HIV-1 infection.

    Ha Youn Lee;Elena E. Giorgi;Elena E. Giorgi;Brandon F. Keele;Brian Gaschen

  • TOX is expressed by exhausted and polyfunctional human effector memory CD8+ T cells

    Takuya Sekine;André Perez-Potti;Son Nguyen;Jean-Baptiste Gorin

  • Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703–positive individuals and their transmission recipients

    Hayley Crawford;Wendy Lumm;Alasdair Leslie;Malinda Schaefer

  • Phase 1 Safety and Immunogenicity Testing of DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-like Particles

    Paul A. Goepfert;Marnie L. Elizaga;Alicia Sato;Li Qin

  • Genetic Selection Bias at the Heterosexual HIV-1 Transmission Bottleneck

    J Carlson;D Monaco;M Schaefer;D Claiborne

Frequent Co-Authors

Eric Hunter
Eric Hunter Emory University
Susan Allen
Susan Allen Emory University
M. Juliana McElrath
M. Juliana McElrath University of Washington
Georgia D. Tomaras
Georgia D. Tomaras Duke University
Philip J. R. Goulder
Philip J. R. Goulder University of Oxford
Richard A. Kaslow
Richard A. Kaslow Yale School of Medicine
David C. Montefiori
David C. Montefiori Duke University
Mark J. Mulligan
Mark J. Mulligan New York University
Jonathan M. Carlson
Jonathan M. Carlson Microsoft (United States)
Bruce D. Walker
Bruce D. Walker Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology opens doors to a variety of related healthcare professions, many of which now offer flexible online degree options. For those interested in advancing clinical skills quickly, accelerated NP programs provide a pathway to becoming a Nurse Practitioner with reduced timeframes through online coursework.

Individuals without prior nursing experience can explore online RN programs for non nurses. These programs enable career changers to enter the nursing field and gain indispensable patient care skills that complement an immunology background.

For aspiring nurses aiming for a Bachelor of Science in Nursing, identifying easiest ABSN to get into can be crucial for a smooth admissions process. These programs often provide a blend of accelerated learning and online education, helping students graduate faster without compromising quality.

Additionally, those seeking foundational licensure may consider best easiest LPN programs to get into. These practical nursing programs offer accessible entry points to healthcare careers, often featuring online components to accommodate diverse schedules.

Overall, the intersection of immunology with nursing and clinical roles through these online degrees creates versatile career pathways suited to various educational backgrounds and professional goals.

Best Scientists Citing Paul A. Goepfert

Trending Scientists

Recently Published Articles